Paper Differential

Row	Disease	Sample Type	Official Symbol	Sign Of Difference	Experimental Design	Control	Case	P Value	Type Of Study	Organism	Variable Category	Case Count	Control Count	Technique	Confidence Interval
1169	CEES Exposure	Liver	CPB2	UP	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
1565	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
1567	CEES Exposure	Liver	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
1568	CEES Exposure	Kidney	SERPINE1	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
1569	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE1	NC	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rattus norvegicus	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)	NM
1570	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE2	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rattus norvegicus	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)	NM
1571	CEES Exposure	Bronchoalveolar Lavage (BAL)	SERPINE3	DOWN	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vitro	Rattus norvegicus	Protein	4	4	Enzyme-linked immunosorbent assay (ELISA)	NM
1634	CEES Exposure	Bronchoalveolar Lavage (BAL)	PLAT	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	3	3	Plasminogen Activator Activity Assay	NM
1635	CEES Exposure	Bronchoalveolar Lavage (BAL)	PLAT	DOWN	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	6	6	Plasminogen Activator Activity Assay	NM
1830	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAT	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	5	5	Enzyme-linked immunosorbent assay (ELISA)	NM
1831	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAT	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	5	5	Enzyme-linked immunosorbent assay (ELISA)	NM
2963	CEES Exposure	Liver	SERPINF2	UP	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
2964	CEES Exposure	Kidney	SERPINF2	UP	Case-Control	CEES Exposure	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Transcript	5	5	Reverse Transcription Polymerase Chain Reaction (RT-PCR)	NM
5168	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAFI activity	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	3	3	Western blot analysis	NM
5169	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAFI activity	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	3	3	Western blot analysis	NM
5170	CEES Exposure	Bronchoalveolar Lavage (BAL)	TAFI activity	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	3	3	Western blot analysis	NM
6616	CEES Exposure	Bronchoalveolar Lavage (BAL)	total protein level	NC	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	3	6	BCA assay	NM
6617	CEES Exposure	Bronchoalveolar Lavage (BAL)	total protein level	UP	Case-Control	Healthy Control	CEES Exposure	<0.05	in vivo	Rattus norvegicus	Protein	6	6	BCA assay	NM

papers

Differential List